Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P50
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
202529.97%
202463.24%
2023157.50%
2022-28.19%
20210.00%